1. Home
  2. Analysis
  3. Effexor
  4. Seebri

Effexor and Seebri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Seebri (glycopyrrolate). Common drug interactions include back pain among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Seebri. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

On Jul, 15, 2026

13 people who take Effexor and Seebri together, and have interactions are studied.

Effexor and Seebri drug interactions.

What are the common drug interactions of Effexor and Seebri, by gender? *:

female:

  1. Back pain
  2. Bacterial infection
  3. Balance disorder
  4. Bone pain
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cataract (clouding of the lens inside the eye)
  7. Consciousness fluctuating
  8. Constipation
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Cystitis (inflammation of the wall of the bladder)

male:

  1. Death
  2. Lung neoplasm malignant (cancer tumour of lung)

What are the common drug interactions of Effexor and Seebri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death

50-59:

n/a

60+:

  1. Blood pressure increased
  2. Asthma
  3. Pneumonia
  4. Productive cough
  5. Speech disorder
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cataract (clouding of the lens inside the eye)
  8. Influenza
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

  1. Asthma: 8 people, 61.54%
  2. Bone Disorder: 4 people, 30.77%
  3. Headache (pain in head): 2 people, 15.38%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Seebri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Seebri and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and glycopyrrolate (the active ingredients of Effexor and Seebri, respectively), and Effexor and Seebri (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.